ASX - By Stock
|
AVR |
Re:
AVR results presentation at CRT 24 Washington DC 9th to 12th March
|
|
Deruyter
|
65 |
24K |
6 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
65
|
24K
|
6
|
|
ASX - By Stock
|
AVR |
Re:
Dr interview from London Valves 2023
|
|
Deruyter
|
10 |
3.6K |
10 |
07/12/23 |
07/12/23 |
ASX - By Stock
|
10
|
3.6K
|
10
|
|
ASX - By Stock
|
AVR |
Re:
For those who are interested
|
|
Deruyter
|
11 |
4.5K |
7 |
25/08/23 |
25/08/23 |
ASX - By Stock
|
11
|
4.5K
|
7
|
|
ASX - By Stock
|
AVR |
Re:
Ann: DurAVR Maintains Exceptional Results in New Patient Cohort
|
|
Deruyter
|
35 |
14K |
22 |
03/06/23 |
03/06/23 |
ASX - By Stock
|
35
|
14K
|
22
|
|
ASX - By Stock
|
SYT |
Re:
Ann: Removal from Official List
|
|
Deruyter
|
18 |
14K |
3 |
13/04/23 |
13/04/23 |
ASX - By Stock
|
18
|
14K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Patent for Transcatheter Heart Valve Replacement Technology
|
|
Deruyter
|
25 |
11K |
16 |
12/04/23 |
12/04/23 |
ASX - By Stock
|
25
|
11K
|
16
|
|
ASX - By Stock
|
WBT |
Re:
Running discussion on SP
|
|
Deruyter
|
8.2K |
3.2M |
46 |
19/02/23 |
19/02/23 |
ASX - By Stock
|
8.2K
|
3.2M
|
46
|
|
ASX - By Stock
|
AVR |
Re:
New proactive vid
|
|
Deruyter
|
18 |
6.6K |
17 |
16/02/23 |
16/02/23 |
ASX - By Stock
|
18
|
6.6K
|
17
|
|
ASX - By Stock
|
WBT |
Re:
Updated research note by Pitt Street Research
|
|
Deruyter
|
7 |
5.7K |
18 |
11/11/22 |
11/11/22 |
ASX - By Stock
|
7
|
5.7K
|
18
|
|
ASX - By Stock
|
WBT |
Re:
SkyWater Technology (NASDAQ: SKYT)
|
|
Deruyter
|
190 |
122K |
7 |
11/08/22 |
11/08/22 |
ASX - By Stock
|
190
|
122K
|
7
|
|
ASX - By Stock
|
WBT |
Re:
WBT Industry Related Off Topic.
|
|
Deruyter
|
1.2K |
563K |
3 |
05/08/22 |
05/08/22 |
ASX - By Stock
|
1.2K
|
563K
|
3
|
|
ASX - By Stock
|
WBT |
Re:
WBT Industry Related Off Topic.
|
|
Deruyter
|
1.2K |
563K |
13 |
05/08/22 |
05/08/22 |
ASX - By Stock
|
1.2K
|
563K
|
13
|
|
ASX - By Stock
|
SPL |
Re:
Ann: US patent issued for DEP cabazitaxel nanoparticle
|
|
Deruyter
|
41 |
10K |
5 |
15/09/21 |
15/09/21 |
ASX - By Stock
|
41
|
10K
|
5
|
|
ASX - By Stock
|
WBT |
Re:
Commercial Partnership[!!
|
|
Deruyter
|
484 |
245K |
18 |
01/09/21 |
01/09/21 |
ASX - By Stock
|
484
|
245K
|
18
|
|
ASX - By Stock
|
SPL |
Re:
Fined $93,240 for alleged unlawful advertising of 'Viraleze' in relation to COVID-19
|
|
Deruyter
|
105 |
30K |
5 |
02/07/21 |
02/07/21 |
ASX - By Stock
|
105
|
30K
|
5
|
|
ASX - By Stock
|
SPL |
Re:
Astra Zeneca Quarterly
|
|
Deruyter
|
31 |
8.9K |
11 |
02/05/21 |
02/05/21 |
ASX - By Stock
|
31
|
8.9K
|
11
|
|
ASX - By Stock
|
SPL |
Re:
Ann: AZD0466 clinical DEP program global expansion
|
|
Deruyter
|
113 |
39K |
23 |
28/03/21 |
28/03/21 |
ASX - By Stock
|
113
|
39K
|
23
|
|
ASX - By Stock
|
SPL |
Re:
Ann: SPL7013 shows potent antiviral activity in RSV
|
|
Deruyter
|
79 |
19K |
18 |
19/11/20 |
19/11/20 |
ASX - By Stock
|
79
|
19K
|
18
|
|
ASX - By Stock
|
BUD |
Re:
Ann: Amazon Launches Alexa-LIFX Bundles, Record Sales Expected
|
|
Deruyter
|
84 |
26K |
8 |
13/10/20 |
13/10/20 |
ASX - By Stock
|
84
|
26K
|
8
|
|
ASX - By Stock
|
SPL |
Re:
SPL Nasal Spray Competition from Ena Respiratory
|
|
Deruyter
|
9 |
7.9K |
4 |
28/09/20 |
28/09/20 |
ASX - By Stock
|
9
|
7.9K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Ann: SPL7013 COVID-19 nasal spray virucidal against SARS-CoV-2
|
|
Deruyter
|
130 |
45K |
4 |
16/09/20 |
16/09/20 |
ASX - By Stock
|
130
|
45K
|
4
|
|
ASX - By Stock
|
WBT |
Re:
Ann: Weebit Nano undertakes upsized $6.6 million Placement
|
|
Deruyter
|
156 |
54K |
9 |
01/07/20 |
01/07/20 |
ASX - By Stock
|
156
|
54K
|
9
|
|
ASX - By Stock
|
SPL |
Re:
Ann: DEP lutetium effective in human prostate cancer model
|
|
Deruyter
|
35 |
11K |
16 |
17/06/20 |
17/06/20 |
ASX - By Stock
|
35
|
11K
|
16
|
|
ASX - By Stock
|
WBT |
Re:
Ann: Trading Halt
|
|
Deruyter
|
93 |
32K |
3 |
10/06/20 |
10/06/20 |
ASX - By Stock
|
93
|
32K
|
3
|
|
ASX - By Stock
|
SYT |
Re:
Ann: Quarterly Activities and Cashflow Report
|
|
Deruyter
|
45 |
19K |
11 |
30/04/20 |
30/04/20 |
ASX - By Stock
|
45
|
19K
|
11
|
|
ASX - By Stock
|
SPL |
Re:
Ann: SPL7013 shows significant activity against coronavirus
|
|
Deruyter
|
180 |
61K |
1 |
15/04/20 |
15/04/20 |
ASX - By Stock
|
180
|
61K
|
1
|
|
ASX - By Stock
|
WBT |
Re:
Ann: Weebit Nano and CEA-Leti unveil brain-inspired demo
|
|
Deruyter
|
157 |
185K |
11 |
09/08/19 |
09/08/19 |
ASX - By Stock
|
157
|
185K
|
11
|
|
ASX - By Stock
|
TSN |
Re:
Ann: Appendix 4D and Half Year Report
|
|
Deruyter
|
9 |
2.8K |
6 |
27/02/19 |
27/02/19 |
ASX - By Stock
|
9
|
2.8K
|
6
|
|
ASX - By Stock
|
WFL |
Re:
A Current Affair tonight
|
|
Deruyter
|
111 |
52K |
1 |
07/09/18 |
07/09/18 |
ASX - By Stock
|
111
|
52K
|
1
|
|
ASX - By Stock
|
WBT |
Re:
Weebit Nano Valuation
|
|
Deruyter
|
45 |
32K |
25 |
04/05/18 |
04/05/18 |
ASX - By Stock
|
45
|
32K
|
25
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Change in Director's Interest Notice - R Thomas
|
|
Deruyter
|
35 |
12K |
23 |
15/03/18 |
15/03/18 |
ASX - By Stock
|
35
|
12K
|
23
|
|
ASX - By Stock
|
WFL |
Re:
Ann: Pharmaceutical Clinical Study Commences
|
|
Deruyter
|
65 |
20K |
5 |
31/01/18 |
31/01/18 |
ASX - By Stock
|
65
|
20K
|
5
|
|
ASX - By Stock
|
WFL |
Re:
Ann: BodyGuard Collaboration Agreement Executed
|
|
Deruyter
|
208 |
80K |
3 |
29/03/17 |
29/03/17 |
ASX - By Stock
|
208
|
80K
|
3
|
|